Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?

Tenaya Therapeutics Ownership Summary

Tenaya Therapeutics is owned by 66.89% institutional investors, 1.18% insiders, and 31.94% retail investors. Column group is the largest institutional shareholder, holding 11.61% of TNYA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.66% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenaya Therapeutics	66.89%	1.18%	31.94%
Sector	Healthcare Stocks	46.80%	8.14%	45.06%
Industry	Biotech Stocks	44.70%	7.99%	47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Column group	9.40M	11.61%	$29.14M
Ra capital management	7.62M	9.41%	$23.63M
Casdin capital	6.73M	8.31%	$20.87M
Blackrock	4.07M	5.03%	$12.63M
Price t rowe associates inc /md/	3.51M	4.34%	$10.89M
Vanguard group	3.16M	3.91%	$9.81M
Octagon capital advisors lp	2.58M	3.18%	$7.99M
Integral health asset management	2.33M	2.87%	$7.21M
Vr adviser	1.56M	1.92%	$4.82M
Ghost tree capital	1.35M	1.67%	$4.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	9.40M	40.88%	$29.14M
Casdin capital	6.73M	1.59%	$20.87M
Ghost tree capital	1.35M	1.31%	$4.18M
Octagon capital advisors lp	2.58M	1.26%	$7.99M
Integral health asset management	2.33M	0.68%	$7.21M
Euclidean capital	1.02M	0.40%	$3.15M
Ra capital management	7.62M	0.31%	$23.63M
Vr adviser	1.56M	0.31%	$4.82M
Stepstone group lp	462.16K	0.29%	$1.43M
Alphabet	915.71K	0.14%	$2.84M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	7.62M	0.31%	1.87M
Adage capital partners gp	1.00M	0.01%	600.00K
Ghost tree capital	1.35M	1.31%	575.00K
Vanguard group	3.16M	0.00%	301.35K
Geode capital management	1.23M	0.00%	189.14K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	1.32M	0.00%	-1.59M
Blackrock	4.07M	0.00%	-626.94K
Octagon capital advisors lp	2.58M	1.26%	-277.80K
Pfm health sciences, lp	-	-	-222.22K
Acadian asset management	11.86K	0.00%	-167.27K

New Positions

Holder	Shares	% Assets	Change	Value
Panagora asset management	52.74K	0.00%	52.74K	$163.51K
Corebridge financial	29.68K	0.00%	29.68K	$91.99K
Algert global	23.84K	0.00%	23.84K	$74.00K
Mirae asset global etfs	22.78K	0.00%	22.78K	$70.61K
Graham capital management	16.23K	0.00%	16.23K	$50.30K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-11.00
Advisor group	-38.00
Federated hermes	-414.00
Metropolitan life insurance co/ny	-2.78K
Nverses capital	-3.30K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	93	-3.13%	57,630,897	1.33%	66	1.36%	51	-5.56%	17	-37.04%
Jun 30, 2024	96	6.67%	56,876,265	1.89%	70	1.23%	54	12.50%	27	3.85%
Mar 31, 2024	90	20.00%	55,822,180	19.53%	75	1.90%	48	33.33%	26	4.00%
Dec 31, 2023	75	-5.06%	46,699,776	-6.12%	63	1.38%	36	-18.18%	25	92.31%
Sep 30, 2023	79	-4.82%	49,741,546	4.38%	67	1.59%	44	-21.43%	13	18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.10M	2.66%	-471.71K
T. Rowe Price New Horizons	2.10M	2.66%	-470.67K
Vanguard Total Stock Mkt Idx Inv	2.06M	2.61%	-
iShares Russell 2000 ETF	1.43M	1.80%	-3.21K
Fidelity Select Biotechnology	1.23M	1.56%	-
Vanguard Institutional Extnd Mkt Idx Tr	691.52K	0.88%	-
abrdn Life Sciences Investors	600.70K	0.76%	50.00K
Fidelity Small Cap Index	567.02K	0.72%	-11.17K
T. Rowe Price New Horizons Tr-Z	554.73K	0.70%	9.11K
iShares Russell 2000 Value ETF	375.02K	0.47%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 18, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	$4.79K
Aug 16, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	$2.34K
Aug 16, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	$1.89K
Aug 16, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	$2.61K
Aug 16, 2024	Tingley Whittemore	Chief Medical Officer	Sell	$4.70K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	7
2024 Q1	2	7
2023 Q3	-	5
2023 Q2	-	-

TNYA Ownership FAQ

Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 66.89%, followed by 1.18% insiders and 31.93% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 44.70%, which Tenaya Therapeutics exceeds.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 11.61%), Ra capital management (7.62M shares, 9.41%), and Casdin capital (6.73M shares, 8.31%). Together, they hold 29.33% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 40.88% of its assets in 9.4M Tenaya Therapeutics shares, valued at 29.14M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Tenaya Therapeutics shares, with 2.66% of its total shares outstanding invested in 2.1M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools